FOR RETAIL INVESTORS
Understand biotech pipelines in plain English
No PhD required. See what drugs companies are developing and when they might be approved.
Sound familiar?
"You bought the stock because someone on Reddit mentioned a 'Phase 3 readout.' But you have no idea what that means or when it's happening."
The Problem
- Biotech is full of confusing jargon
- Company IR sites assume you're an expert
- ClinicalTrials.gov is overwhelming
- Easy to miss important dates
With TheraRadar
- Plain-English explanations
- Simple drug and company pages
- Key dates highlighted clearly
- Learn as you research
Biotech Basics
Terms you'll see when researching biotech stocks
How Retail Investors Use TheraRadar
Research that actually makes sense
Research Before Buying
"What does this biotech company actually do?"
Understand a Drug
"What is Keytruda and why is it important?"
Track Your Holdings
"When is the next catalyst for my stocks?"
Learn the Basics
"What does "Phase 3" actually mean?"
Built for Regular People
Plain English
Drug summaries without medical jargon
Simple Visuals
Pipeline charts that make sense at a glance
Watchlist
Track stocks and get catalyst alerts
Learn as You Go
Tooltips explain terms throughout the site
See It In Action
KEYTRUDA (pembrolizumab)
Merck • Cancer Treatment
In plain English: Keytruda is a cancer drug that helps your immune system recognize and attack tumors. It's approved for 38 different cancer types and is Merck's best-selling drug.